搜索优化
English
搜索
Copilot
图片
视频
地图
资讯
购物
更多
航班
旅游
酒店
房地产
笔记本
Top stories
Sports
U.S.
Local
World
Science
Technology
Entertainment
Business
More
Politics
过去 30 天
时间不限
过去 1 小时
过去 24 小时
过去 7 天
按相关度排序
按时间排序
Medical News Today
3 小时
Drinking about 4 cups of coffee daily may reduce risk for head and neck cancer
A new study found that drinking certain amounts of caffeinated coffee and tea was linked to a decreased risk for head and ...
MyJoyOnline
2 天
Oral sex identified as leading cause of throat cancer
Oral sex has now been identified as the leading cause of throat cancer, overtaking smoking, alcohol consumption, and poor ...
2 天
Oral sex is the leading cause of throat cancer
Hisham Mehanna, a professor at the University of Birmingham's Institute of Cancer and Genomic Sciences, has conducted ...
modernghana.com
2 天
Oral sex is the leading cause of throat cancer — Study
A recent research by Hisham Mehanna, Professor at the Institute of Cancer and Genomic Sciences, University of Birmingham, has ...
3news
2 天
Oral sex linked to increased risk of throat cancer – Study
A new study suggests a strong link between oral sex and throat cancer, particularly among those with multiple partners.
Endocrinology Advisor
12 天
Many Lack Knowledge of Link Between HPV and Oropharyngeal Cancer
Knowledge of the association between human papillomavirus (HPV) and oropharyngeal squamous cell carcinoma (OPSCC) is poor and ...
Medscape
2 天
NECTORS for Advanced HPV-Related Head and Neck Cancer?
Neoadjuvant chemotherapy followed by transoral robotic surgery (NECTORS) and neck dissection led to better survival outcomes ...
Pharmaceutical Technology
10 天
DPXE-7 by BioVaxys Technology for Oropharyngeal Cancer: Likelihood of Approval
DPXE-7 is under clinical development by BioVaxys Technology and currently in Phase II for Oropharyngeal Cancer.
manilastandard
9 小时
Make your health a priority this 2025
A balanced diet rich in vitamins like C, D, B6, B12, Omega-3, calcium, and iron supports immunity and hormonal balance. Add ...
Pharmaceutical Technology
16 天
Tiragolumab by Genentech USA for Oropharyngeal Cancer: Likelihood of Approval
Tiragolumab is under clinical development by Genentech USA and currently in Phase II for Oropharyngeal Cancer.
1 天
Oral Sex fingered as leading cause of throat cancer
A alarming trend has emerged in the medical community, with oral sex being identified as the leading cause of throat cancer, ...
一些您可能无法访问的结果已被隐去。
显示无法访问的结果
反馈